Subsequently, we selected two CRC cell lines with high glycolytic activity (SW480 and HCT116) (16) for PCED1A overexpression and knockdown interventions to examine its effects on CRC cell functions. This evidence concerns the gene PCED1A and colorectal carcinoma.